• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    BioVersys Gets EIB Funds to Address Antimicrobial Resistance

    Microbiologics Expands Virology Services

    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

    Executive Moves: Novavax

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Ensuring Pharma Manufacturing Quality

    Exploring ICP-MS expertise at Almac

    Catalent Biologics Completes Madison Expansion

    Ascendia Pharmaceuticals Poised for Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance

    Microbiologics Expands Virology Services

    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Exploring ICP-MS expertise at Almac
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    PCI Pharma Services

    Baxter BioPharma Solutions

    Quotient Sciences

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Adare Pharma Solutions

    PCI Pharma Services

    Baxter BioPharma Solutions

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Axxam and Fujifilm Cellular Dynamics Enter Alliance

    Partner to deliver integrated hiPSC drug discovery solutions.

    Related CONTENT
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    • PharmParts – This Makes Sense!
    • CordenPharma Enters Alliance with Nanos of South Korea
    • RBQM Comes of Age: COVID as a Catalyst for Change
    Contract Pharma Staff10.08.20
    Axxam S.p.A., a provider of integrated drug discovery services across life sciences industries, and Fujifilm Cellular Dynamics Inc., a developer and manufacturer of human induced pluripotent stem  cell (hiPSC) models and therapies, have announced a strategic alliance to improve the drug discovery process. The alliance will provide drug discovery researchers and scientists access to an integrated platform of hiPSC-based assays, through the application of advanced drug discovery technologies to enable target assessment, High-Throughput Screening (HTS), and High-Content Screening.   
     
    Through collaboration with Fujifilm Cellular Dynamics, Axxam will increase its portfolio of human disease-relevant cellular models used in the development of new assays for target assessment and compound screening. Fujifilm Cellular Dynamics’ expertise in hiPSC development and manufacture, enables standardized and homogenous batches of hiPSC-derived cells, ensuring reproducible large-scale screens and long-term projects.
     
    The strategic alliance will enable Fujifilm Cellular Dynamics to offer customers a broader range of applications for drug discovery screening by leveraging Axxam’s wealth of experience in setting up cell-based HTS assays and running Hit Discovery Programs for industrial partners. As part of the collaboration, Axxam will provide its deep understanding of the screening process, data analysis and hit selection criteria, for the development of new hiPSC-based applications.
     
    “hiPSCs derived cells are becoming increasingly important for the drug discovery process, representing a more physiologically relevant cellular environment with a big impact on translational aspects even in the very early phases of the drug discovery process, like target validation and compound screening. Therefore, we are very pleased to announce this strategic alliance with Fujifilm Cellular Dynamics,” commented Stefan Lohmer, chief executive officer of Axxam. “As the leading expert in the hiPSC field, Fujifilm Cellular Dynamics has high-quality standards, which are fundamental for conducting robust discovery projects. The complementary technical know-how between Axxam and Fujifilm Cellular Dynamics along with a common philosophy based on scientific excellence will provide clients with tailor made cutting-edge solutions.” 
     
    Nick Manusos, chief operating officer, Fujifilm Cellular Dynamics Inc., added, “Our scientists have devoted 13 years of collective effort to innovating in the field of hiPSCs and establishing processes that enable robust differentiation into over 16 different cell types. Today, we are pleased to offer even more hiPSC-based drug discovery solutions through our alliance with Axxam. Our new integrated hiPSC offering will enable scientists and researchers to approach even more drug discovery and early development projects with biologically-relevant cells, which will have a profound impact on the way research is conducted.”
    Related Searches
    • Bioassay Development
    • Drug Discovery
    • Bioanalytical Services
    Suggested For You
    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    PharmParts – This Makes Sense! PharmParts – This Makes Sense!
    CordenPharma Enters Alliance with Nanos of South Korea CordenPharma Enters Alliance with Nanos of South Korea
    RBQM Comes of Age: COVID as a Catalyst for Change RBQM Comes of Age: COVID as a Catalyst for Change
    Fast Track Automation in Pharmaceutical Manufacturing Fast Track Automation in Pharmaceutical Manufacturing
    BioCentriq, Kytopen Enter Cell Therapy Alliance BioCentriq, Kytopen Enter Cell Therapy Alliance
    Evotec, Takeda Enter Multi-RNA Target Alliance Evotec, Takeda Enter Multi-RNA Target Alliance
    Rentschler, Leukocare Extend Service Offering with U.S. Site Rentschler, Leukocare Extend Service Offering with U.S. Site
    Gilead, Novo Nordisk Expand NASH Alliance Gilead, Novo Nordisk Expand NASH Alliance
    Stiris Research Inc. Stiris Research Inc.
    Process Intensification: Understanding the Optimal Way to Maximize Productivity Process Intensification: Understanding the Optimal Way to Maximize Productivity
    Vetter Establishes Office in China Vetter Establishes Office in China
    Emergent CDMO Capabilities - Perfecting Your Formula Emergent CDMO Capabilities - Perfecting Your Formula
    5 Reasons Paper Has No Place in Contract Manufacturing 5 Reasons Paper Has No Place in Contract Manufacturing

    Related Breaking News

    • Analytical Services | Bioanalytical Services | Breaking News | Industry News
      Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

      Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

      Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.
      Kristin Brooks 04.08.21

    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.
      Tim Wright, Editor, Contract Pharma 04.07.21

    • Bioanalytical Services | Breaking News | CRO News | Industry News
      Charles River Acquires Retrogenix

      Charles River Acquires Retrogenix

      Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.
      Tim Wright, Editor, Contract Pharma 04.05.21


    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Evotec, Takeda Enter Multi-RNA Target Alliance

      Evotec, Takeda Enter Multi-RNA Target Alliance

      To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.
      Kristin Brooks 03.22.21

    • Bioanalytical Services | Breaking News
      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Adds ‘off the shelf’ PK profiling capabilities to its portfolio.
      Charles Sternberg, Assistant Editor 03.04.21

    • Bio News | Breaking News | Collaborations & Alliances | CRO News | Drug Development | Drug Discovery | Industry News | R&D
      Innoforce and dMed Enter Development Collaboration

      Innoforce and dMed Enter Development Collaboration

      Aims to accelerate the development of innovative therapeutics.
      Tim Wright, Editor, Contract Pharma 03.03.21


    • Breaking News | CRO News | Drug Discovery | Industry News | R&D
      Icon to Acquire PRA Health Sciences

      Icon to Acquire PRA Health Sciences

      Brings together two organizations to create a leading healthcare intelligence and clinical CRO.
      Charles Sternberg, Assistant Editor 03.01.21

    • Analytical Services | Breaking News | Drug Discovery | Facilities | Industry News | R&D
      CatSci Opens New Site in UK

      CatSci Opens New Site in UK

      Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.
      Tim Wright, Editor, Contract Pharma 02.25.21

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
      CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing

      CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing

      Will leverage quantum machine learning for novel cancer treatment biomarker discovery.
      Tim Wright, Editor, Contract Pharma 02.25.21


    • Bioanalytical Services | Breaking News | Industry News | Preclinical Outsourcing
      Altasciences Contributes to Vibegron Approval

      Altasciences Contributes to Vibegron Approval

      Provided clinical support for two drug-drug interaction studies and a bioavailability trial for the overactive bladder treatment.
      Kristin Brooks 02.24.21

    • Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Facilities | Industry News | Laboratory Testing | R&D
      Almac Group Completes $7M R&D Center

      Almac Group Completes $7M R&D Center

      Significant expansion of biocatalysis, flow chemistry, and peptide capacity.
      Tim Wright, Editor, Contract Pharma 02.23.21

    • Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
      Jubilant Biosys, Yale Form Research Alliance

      Jubilant Biosys, Yale Form Research Alliance

      Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.
      02.10.21


    • Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Industry News | Laboratory Testing
      Element Materials Technology Acquires Avomeen

      Element Materials Technology Acquires Avomeen

      Bolsters offering in key strategic growth areas, including formulation chemistry, product manufacturing, extractables & leachables, and large molecule testing.
      Kristin Brooks 02.03.21

    • Analytical Services | Bio News | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing
      Frontida Expands Testing Capabilities

      Frontida Expands Testing Capabilities

      Launches CAT.one testing to support abuse-deterrent product development.
      Tim Wright, Editor, Contract Pharma 02.02.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
      Evozyne, Takeda Ink Strategic Protein Design Agreement

      Evozyne, Takeda Ink Strategic Protein Design Agreement

      Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.
      Kristin Brooks 01.28.21

    Trending
    • Astellas, Affinivax In Global MAPS Vax Pact
    • Ascendia Pharmaceuticals Poised For Expansion
    • Executive Moves: Novavax
    • Sanofi Invests In Cutting Edge Vax Production Site In Singapore
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    Breaking News
    • BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    • Microbiologics Expands Virology Services
    • ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    • Executive Moves: Novavax
    • Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status
    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13
    Bunge Invests $47.5 Million in Australian Plant Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    VideoBite: Engineered Polymer Solutions
    Shepherd Color Unveils Bismuth Vanadate Yellow Pigment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Medtronic Introduces Extended Infusion Set in Europe
    BioSig Launches Software Update for PURE EP Electrophysiology Platform
    Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    Microbiologics Expands Virology Services
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cosmoprof Worldwide Bologna Postpones 2021 Show
    Native Launches Broad Spectrum SPF 30 Mineral Sunscreens
    Revieve Launches Skin Coach
    Happi

    Latest Breaking News From Happi

    Hallstar Beauty Names New President
    The Fragrance Foundation Announces the 2021 Awards Finalists
    Azelis Earns 'Coup de Coeur' Award at Cosmetagora 2021
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson SurePress reaches milestone
    Maxcess updates user interface for Fife guiding Sensor
    Bobst announces virtual packaging industry event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    PCMC Redesigns Rx200 and Mako Clipper Wet Wipes Machines
    PFNonwovens Adding New Capabilities in Znojmo
    Russ Torres Named Group President of Kimberly-Clark North America
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Biogennix Rolls Out Agilon Strip Bone Graft
    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations
    SUPERSMART Wins 'Best Publicly Funded Project Demonstrator' in 2021 OE-A Competition

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login